Brad Hirsh, CEO and co-founder of SignalPath, talks artificial intelligence and medical trials with Infinia ML’s James Kotecki on Machine Meets World.
Recorded July 7th, 2020.
“There are so many levels of opportunity for automation in clinical trials and clinical research.” [5:16]
Why SignalPath automation doesn’t put jobs at risk [7:06 and 9:35]
The next frontier for automation in clinical trials [14:41]
The promise of less busywork and more helpful science [17:10]
Optimism for the future of clinical trials [25:32]